Chimerix Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 2.48, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2024. Average receivable collection period, for the Chimerix Inc in Dec 31 2024 quarter, has decreased to 147 days, compared to 166 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector Chimerix Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Chimerix Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CMRX Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	1325 %	1309.09 %	396.15 %	-99.85 %	-99.62 %
Y / Y Revenue Change	1325 %	136.36 %	396.15 %	-	-99.51 %
Receivable Turnover Ratio (TTM)	2.48	2.2	3.97	3.9	1.83
CMRX's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	147	166	92	93	200
Seq. Receivable Change	-63.23 %	20.16 %	12800 %	-75 %	-63.64 %
Seq. Revenue Change	119.23 %	-79.84 %	-	-	-63.64 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

CMRX Company Profile • Back to CMRX Efficiency Comparisons • Compare CMRX Receivables Turnover Ratio to its Competitors

Financial Statements
Chimerix Inc 's Accounts Receivable	$ 0 Millions	Visit CMRX's Balance sheet
Chimerix Inc 's Sales TTM	$ 0 Millions	Visit CMRX's Income Statement
Sources of CMRX's Revenues		Visit CMRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CMRX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CMRX's Growth Rates	CMRX's Roa	CMRX's Inventory Turnover Ratio	CMRX's Dividend Comparisons
CMRX's Profitability Ratios	CMRX's Roi	CMRX's Asset Turnover Ratio	CMRX's Dividend Growth
CMRX's Valuation Ratios	CMRX's Roe	CMRX's Financial Strength Ratios	CMRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Strata Critical Medical Inc	10.22	$ 248.693 Millions	$ 24.336 Millions
Fractyl Health Inc	10.05	$ 0.093 Millions	$ 0.009 Millions
Sunshine Biopharma Inc	10.04	$ 34.874 Millions	$ 3.472 Millions
Quidelortho Corp	9.95	$ 2,782.900 Millions	$ 279.625 Millions
Immucell Corporation	9.95	$ 26.493 Millions	$ 2.663 Millions
Lensar Inc	9.82	$ 53.494 Millions	$ 5.447 Millions
Neurometrix Inc	9.81	$ 2.680 Millions	$ 0.273 Millions
Dih Holding Us Inc	9.79	$ 112.019 Millions	$ 11.440 Millions
Nexgel Inc	9.77	$ 7.748 Millions	$ 0.793 Millions
Lipella Pharmaceuticals Inc	9.75	$ 0.536 Millions	$ 0.055 Millions
Biontech Se	9.71	$ 3,081.232 Millions	$ 317.296 Millions
Inmode Ltd	9.62	$ 394.818 Millions	$ 41.032 Millions
Escalon Medical Corp	9.60	$ 12.169 Millions	$ 1.268 Millions
Surmodics Inc	9.59	$ 125.448 Millions	$ 13.077 Millions
Inogen Inc	9.59	$ 335.705 Millions	$ 35.014 Millions
Inspire Medical Systems inc	9.58	$ 801.818 Millions	$ 83.715 Millions
American Oncology Network Inc	9.50	$ 1,759.484 Millions	$ 185.223 Millions
Alpha Pro Tech Ltd	9.49	$ 56.933 Millions	$ 6.002 Millions
Genedx Holdings Corp	9.45	$ 305.397 Millions	$ 32.324 Millions
Adma Biologics Inc	9.45	$ 424.769 Millions	$ 44.968 Millions
United Therapeutics Corporation	9.44	$ 2,877.400 Millions	$ 304.775 Millions
Travere Therapeutics Inc	9.38	$ 233.175 Millions	$ 24.871 Millions
Bgm Group Ltd	9.37	$ 24.115 Millions	$ 2.573 Millions
Ensysce Biosciences Inc	9.36	$ 5.210 Millions	$ 0.557 Millions
Fresenius Medical Care Ag	9.35	$ 21,656.218 Millions	$ 2,316.073 Millions
Twist Bioscience Corporation	9.29	$ 330.189 Millions	$ 35.550 Millions
Brainsway Ltd	9.27	$ 41.016 Millions	$ 4.426 Millions
Biolinerx Ltd	9.20	$ 28.940 Millions	$ 3.145 Millions
Siga Technologies Inc	9.20	$ 138.719 Millions	$ 15.084 Millions
Enanta Pharmaceuticals Inc	9.11	$ 66.591 Millions	$ 7.306 Millions

Date modified: 2026-09-08T15:11:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.